BioSpace News Archive

Revenues of $43.3 Billion for the Fourth Quarter, a 10.7 Percent Increase Year-Over-Year

Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for Dupixent® (dupilumab) in adolescent patients 12 to 17 years of age with moderate-to-severe atopic dermatitis, whose disease was inadequately controlled with topical therapies or for whom topical treatment was medically inadvisable.

The 124th China Import and Export Fair (Canton Fair), has gathered more than 8,600 companies from the areas of textiles and garments, shoes, cases and bags, recreational products, medicine and healthcare products and food to showcase their market-driven ideas and designs to global buyers during its Phase 3 exhibition.

Technology to be presented at the 3D Printing and Beyond Conference at The Hebrew University of Jerusalem on November 7, 2018

AlgaEnergy and Yokogawa Electric Corporation announce the signing of a partnership & equity participation agreement. The strategic agreement involves an approximately 10 million euro investment by Yokogawa to acquire newly issued shares of AlgaEnergy, making the Japanese company a reference shareholder.

Biotage continues to grow with increased profitability

A&D Medical has partnered with Health Recovery Solutions (HRS) to bring the most cutting edge biometric monitoring equipment to patients using the HRS platform.

Financial release accessible online

Net sales of $640.0 million, up 6.6%, or 6.7% on a constant-currency basis

Appointment of Dr. Goessens-Rueck strengthens management team and fulfils commitment to promote female leadership in biotech